{"doi":"10.65140/ebcm202501.5","title":"免疫检查点抑制剂在前列腺癌治疗中的临床应用进展","abstract":"<jats:p>前列腺癌是男性常见癌症，其死亡人数逐年增加，对男性生命健康构成严重威胁。前列腺癌治疗包括根治性前列腺切除术、放疗和激素治疗，但有些患者经激素治疗后会进展为去势抵抗性前列腺癌（castration-resistant prostate cancer, CRPC）。CRPC患者早期易转移且缺乏治疗手段。近年来，免疫检查点阻断是目前治疗转移性去势抵抗性前列腺癌（metastatic castration-resistant prostate cancer, mCRPC）的研究热点，通过阻断免疫检查点的关键分子从而增强T细胞抗肿瘤活性，实现治疗的目的。本文就免疫检查点抑制剂单药及联合治疗在前列腺癌治疗中的临床应用进展进行综述。</jats:p>","journal":"临床医药循证研究","year":2025,"id":622567,"datarank":0.32958368660043297,"base_score":2.1972245773362196,"endowment":2.1972245773362196,"self_citation_contribution":0.32958368660043297,"citation_network_contribution":0.0,"self_endowment_contribution":0.32958368660043297,"citer_contribution":0.0,"corpus_percentile":47.6,"corpus_rank":6967,"citation_count":8,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":true,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1608663,"name":"荣 孙","orcid":null,"position":1,"is_corresponding":false},{"id":1608664,"name":"彬 周","orcid":null,"position":2,"is_corresponding":false},{"id":1608665,"name":"向东 孙","orcid":null,"position":3,"is_corresponding":false},{"id":1608662,"name":"嘉豪 尧","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"免疫检查点抑制剂在前列腺癌治疗中的临床应用进展","abstract":"<jats:p>前列腺癌是男性常见癌症，其死亡人数逐年增加，对男性生命健康构成严重威胁。前列腺癌治疗包括根治性前列腺切除术、放疗和激素治疗，但有些患者经激素治疗后会进展为去势抵抗性前列腺癌（castration-resistant prostate cancer, CRPC）。CRPC患者早期易转移且缺乏治疗手段。近年来，免疫检查点阻断是目前治疗转移性去势抵抗性前列腺癌（metastatic castration-resistant prostate cancer, mCRPC）的研究热点，通过阻断免疫检查点的关键分子从而增强T细胞抗肿瘤活性，实现治疗的目的。本文就免疫检查点抑制剂单药及联合治疗在前列腺癌治疗中的临床应用进展进行综述。</jats:p>","is_dataset_classified":null,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19910364","pmcid":null,"openalex_id":"https://openalex.org/W4415295494","authors":[],"funders":[],"total_grants":0,"fwci":2.754,"citation_percentile":0.91273694,"influential_citations":0,"citation_trend":[{"year":2025,"count":1},{"year":2026,"count":2}],"oa_status":"hybrid","license":"cc-by","oa_locations":[{"url":"https://pangu.press/journal/ebcm/1/1/5/pdf","host_type":"journal"},{"url":"https://pangu.press/journal/ebcm/1/1/5/pdf","host_type":"publisher"},{"url":"https://www.pangupress.com/journal/ebcm/1/1/5/pdf","host_type":"publisher"},{"url":"https://doi.org/10.65140/ebcm202501.5","host_type":"journal"}],"fields_of_study":["Prostate Cancer Treatment and Research"],"mesh_terms":[],"keywords":["Prostate","Prostate cancer","Prostate disease","TSG101"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-03T20:07:20.902665Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}